Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

The association between the IGF-I axis, thyroid hormones and cortical bone in patients with mild primary hyperparathyroidism.

Simintiriadis D, Bondeson AG, Bondeson L, Svensson J, Almqvist EG.

Scand J Clin Lab Invest. 2013 Feb;73(1):34-41. doi: 10.3109/00365513.2012.733409. Epub 2012 Oct 25.

PMID:
23098341
2.

Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis.

Boonen S, Mohan S, Dequeker J, Aerssens J, Vanderschueren D, Verbeke G, Broos P, Bouillon R, Baylink DJ.

J Bone Miner Res. 1999 Dec;14(12):2150-8.

4.

Growth hormone, insulin growth factor-1, and igf binding protein-3 axis relationship with bone mineral density among healthy men.

Krassas GE, Papadopoulou P, Koliakos G, Konstantinidis T, Kalothetou K.

Arch Androl. 2003 May-Jun;49(3):191-9.

PMID:
12746097
5.

Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism.

Moosgaard B, Christensen SE, Vestergaard P, Heickendorff L, Christiansen P, Mosekilde L.

Clin Endocrinol (Oxf). 2008 May;68(5):707-15. Epub 2007 Nov 2.

PMID:
17980013
6.
7.

Age, body mass index, current smoking history, and serum insulin-like growth factor-I levels associated with bone mineral density in middle-aged Korean men.

Rhee EJ, Oh KW, Lee WY, Kim SW, Oh ES, Baek KH, Kang MI, Park CY, Choi MG, Yoo HJ, Park SW.

J Bone Miner Metab. 2004;22(4):392-8.

PMID:
15221500
8.

Serum insulin-like growth factor-I, insulin-like growth factor binding proteins, and bone mineral content in hyperthyroidism.

Lakatos P, Foldes J, Nagy Z, Takacs I, Speer G, Horvath C, Mohan S, Baylink DJ, Stern PH.

Thyroid. 2000 May;10(5):417-23.

PMID:
10884189
9.

Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy.

Thorén M, Hilding A, Brismar T, Magnusson P, Degerblad M, Larsson L, Sääf M, Baylink DJ, Mohan S.

J Bone Miner Res. 1998 May;13(5):891-9.

10.

Concentration of insulin-like growth factor (IGF)-I in iliac crest bone matrix in premenopausal women with idiopathic osteoporosis.

Pepene CE, Seck T, Diel I, Minne HW, Ziegler R, Pfeilschifter J.

Exp Clin Endocrinol Diabetes. 2004 Jan;112(1):38-43.

PMID:
14758570
11.

Bone mineral density in femoral neck is positively correlated to circulating insulin-like growth factor (IGF)-I and IGF-binding protein (IGFBP)-3 in Swedish men.

Gillberg P, Olofsson H, Mallmin H, Blum WF, Ljunghall S, Nilsson AG.

Calcif Tissue Int. 2002 Jan;70(1):22-9. Epub 2001 Dec 21.

PMID:
11907704
12.

Growth hormone-dependent insulin-like growth factor binding protein is a major determinant of bone mineral density in healthy men.

Johansson AG, Forslund A, Hambraeus L, Blum WF, Ljunghall S.

J Bone Miner Res. 1994 Jun;9(6):915-21.

PMID:
7521562
13.

Bone metabolism in patients with primary hyperparathyroidism before and after surgery.

Kerschan-Schindl K, Riss P, Krestan C, Rauner M, Bieglmayer C, Gleiss A, Fialka-Moser V, Niederle B, Pietschmann P.

Horm Metab Res. 2012 Jun;44(6):476-81. doi: 10.1055/s-0032-1308998. Epub 2012 Apr 11.

PMID:
22495973
14.

Association between thyroid hormone levels, the number of circulating osteoprogenitor cells, and bone mineral density in euthyroid postmenopausal women.

Pirro M, Manfredelli MR, Scarponi AM, Lupattelli G, Bagaglia F, Melis F, Mannarino E.

Metabolism. 2012 Apr;61(4):569-76. doi: 10.1016/j.metabol.2011.09.006. Epub 2011 Nov 9.

PMID:
22075271
15.

Low serum concentrations of insulin-like growth factor I are associated with femoral bone loss in a population-based sample of postmenopausal women.

Seck T, Scheidt-Nave C, Leidig-Bruckner G, Ziegler R, Pfeilschifter J.

Clin Endocrinol (Oxf). 2001 Jul;55(1):101-6.

PMID:
11453958
16.

Evaluation of changes in bone density and biochemical parameters after parathyroidectomy in primary hyperparathyroidism.

Nakaoka D, Sugimoto T, Kobayashi T, Yamaguchi T, Kobayashi A, Chihara K.

Endocr J. 2000 Jun;47(3):231-7.

17.

A potentially deleterious role of IGFBP-2 on bone density in aging men and women.

Amin S, Riggs BL, Atkinson EJ, Oberg AL, Melton LJ 3rd, Khosla S.

J Bone Miner Res. 2004 Jul;19(7):1075-83. Epub 2004 Mar 22.

18.

Insulin-like growth factor I is a determinant of hip bone mineral density in men less than 60 years of age: MINOS study.

Szulc P, Joly-Pharaboz MO, Marchand F, Delmas PD.

Calcif Tissue Int. 2004 Apr;74(4):322-9.

PMID:
15255068
19.
20.

Increase of bioavailable testosterone is associated with gain in bone mineral density after cure of primary hyperparathyroidism in postmenopausal women.

Almqvist EG, Becker C, Bondeson AG, Bondeson L, Svensson J.

Clin Endocrinol (Oxf). 2006 Jan;64(1):58-62.

PMID:
16402929

Supplemental Content

Support Center